InvestorsHub Logo

nidan7500

09/13/17 9:25 AM

#119993 RE: attilathehunt #119983

Missling is waiting for there FDA



Yup, have felt that way for long time. W/O FDA protocols being public he cannot go public on details (see silence). And, BTW I do also think the plan all along has been for Rett (others possible) to be poster child for new trials planning.

Investor2014

09/13/17 9:27 AM

#119995 RE: attilathehunt #119983

It may also be important to Anavex that with the new FDA rules patient and caregiver testimony could carry more weight than before raising prospects of approval without fully supportive data. A la what happened recently with the approval of Sarepta's Eteplersin for DMD.